Logo Logo
Group by: Item Type | Date
Jump to: 2021 | 2019 | 2017
Number of items: 3.

2021

Evans, Denise; Rensburg, Craig van; Govathson, Caroline; Ivanova, Olena; Riess, Friedrich; Siroka, Andrew; Sillah, Abdou K.; Ntinginya, Nyanda Elias; Jani, Ilesh; Sathar, Farzana; Rosen, Sydney; Sanne, Ian; Rachow, Andrea and Lonnroth, Knut (2021): Adaptation of WHO's generic tuberculosis patient cost instrument for a longitudinal study in Africa. In: Global Health Action, Vol. 14, No. 1, 1865625

2019

Rachow, Andrea; Ivanova, Olena; Wallis, Robert; Charalambous, Salome; Jani, Ilesh; Bhatt, Nilesh; Kampmann, Beate; Sutherland, Jayne; Ntinginya, Nyanda E.; Evans, Denise; Lönnroth, Knut; Niemann, Stefan; Schaible, Ulrich E.; Geldmacher, Christof; Sanne, Ian; Hölscher, Michael and Churchyard, Gavin (2019): TB sequel: incidence, pathogenesis and risk factors of long-term medical and social sequelae of pulmonary TB – a study protocol. In: BMC Pulmonary Medicine 19:4 [PDF, 755kB]

2017

Boeree, Martin J.; Heinrich, Norbert; Aarnoutse, Rob; Diacon, Andreas H.; Dawson, Rodney; Rehal, Sunita; Kibiki, Gibson S.; Churchyard, Gavin; Sanne, Ian; Ntinginya, Nyanda E.; Minja, Lilian T.; Hunt, Robert D.; Charalambous, Salome; Hanekom, Madeleine; Semvua, Hadija H.; Mpagama, Stellah G.; Manyama, Christina; Mtafya, Bariki; Reither, Klaus; Wallis, Robert S.; Venter, Amour; Narunsky, Kim; Mekota, Anka; Henne, Sonja; Colbers, Angela; Plemper van Balen, Georgette; Gillespie, Stephen H.; Phillips, Patrick P. J. and Hölscher, Michael (2017): High-dose rifampicin, moxifloxacin, and SQ109 for treating tuberculosis: a multi-arm, multi-stage randomised controlled trial. In: Lancet infectious Diseases, Vol. 17, No. 1: pp. 39-49

This list was generated on Sun Sep 17 01:30:15 2023 CEST.